top of page

jumbo phages have unique
biological properties of high
potential to develop novel
technologies targeting top priority AMR pathogens

News & PRess

jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png

> OCT '24

patrick guye joins Kinzbio

Kinzbio announces the appointment of its first iNED

We are excited to announce that Patrick Guye PhD/MBA has assumed the role of Independent Non-Executive Director at Kinzbio. His knack for cultivating growth through strategic partnerships in therapeutic, consumer and B2B arenas positions us at the forefront of innovation and commercial success.

​​

Dr. Guye joins the company with a robust background in microbiology and strategic business management, poised to drive Kinzbio's growth and expansion during this pivotal time. His deep expertise in infection biology, extensive experience in therapeutic development and biomedical product management, coupled with a proven track record of guiding startups to success, align perfectly with Kinzbio’s ambitious goals.

​

​

​

​

DSC00443_1600px.png
Swiss-knife-Victorinox-Work-Champ-21-fun

unleashing the potential of
Jumbo phages
together

Kinzbio fosters collaborations and partnerships with pharma leaders, clinical organizations, academic labs and funding agencies to help the company to accelerate the development of its jumbo phage platform and pipeline.

Kinzbio has an open communication channel with and is always seeking to hear from industry partners and funding institutions interested in joining efforts to keep developing applications based on the biology of jumbo phages.
 

BE IN

TOUCH

Please fill your contact details below:

Thanks for contact us!

Phage technologies for a

healthier world

Microbiome_edited.png

ANtimicrobial
resistance is one
of the major global
health issues that
humanity is facing

every year millions
of lives are lost and
billions are spent in
prevention and
treatment of AMR

phages are natural
bacterial killers
that can be used to
combat AMR pathogens

3305040.png
3305040.png
c1ece665a7319e22602d0d90426d3be5_edited_
3305040.png
3305040.png
3305040.png
News
Partnering
Contact
bottom of page